U.S. Research ELISA Markets
Topics: In Vitro Diagnostics, AIDS, HIV & STDs, Allergy/Immunology
Regions: United States
|
HIV Vaccine Update: R&D Innovation Critical in the Wake of Recent Setbacks
Topics: AIDS, HIV & STDs, Vaccines
|
Pipeline Insight: HIV - Novel NNRTIs address crucial unmet need
Topics: AIDS, HIV & STDs, Drug Discovery
|
Stakeholder Insight: Hiv Therapy Dynamics
Topics: AIDS, HIV & STDs, Research & Development, Prescription Drugs, Drug Discovery
|
Chinese Markets for HIV Treatment Drugs
Topics: AIDS, HIV & STDs
Regions: China
|
Commercial Insight: HIV - Reshaping Treatment Paradigms
Topics: AIDS, HIV & STDs
|
The Global HIV/AIDS Market Outlook to 2012
Topics: In Vitro Diagnostics, AIDS, HIV & STDs, Prescription Drugs
Regions: Global
|
Infections - Herpes Simplex Virus Infection Drug Pipeline Report
Topics: AIDS, HIV & STDs, Drug Discovery
|
Infections - AIDS HIV Drug Pipeline Report
Topics: AIDS, HIV & STDs, Drug Discovery
|
Infections - Hepatitis C Drug Pipeline Report
Topics: AIDS, HIV & STDs, Drug Discovery
|
Stakeholder Opinions: Hepatocellular Carcinoma - Opportune indication for novel therapies
Topics: AIDS, HIV & STDs, Infectious Diseases, Oncology/Hematology
|
The Global Antivirals Market: R&D Pipelines, Market Analysis and Competitive Landscape
Topics: AIDS, HIV & STDs, Microbiology & Virology, Research & Development
|
Anti-Infectives: World Market, 2nd Edition, Vol III: Antivirals
Topics: AIDS, HIV & STDs, Pharmaceuticals, Infectious Diseases
Regions: Global
|
Updated CDC HIV Testing Guidelines to Shape Evolving Diagnostics Market
Topics: AIDS, HIV & STDs, Microbiology & Virology
|
Infectious Disease Diagnostics Markets in sub-Saharan Africa
Topics: AIDS, HIV & STDs, Drug Delivery, Infectious Diseases
Regions: Africa
|
Commercial Insight: HIV - Change of guard
Topics: AIDS, HIV & STDs, Research & Development
Regions: United States, Europe
|
Antivirals
Topics: AIDS, HIV & STDs, Hepatitis, Pharmaceuticals, Prescription Drugs, Infectious Diseases
Regions: Global
|
Pipeline Insight: HIV - Extending Treatment Options
Topics: AIDS, HIV & STDs, Research & Development, Drug Discovery
|
HIV/AIDS Testing
Topics: AIDS, HIV & STDs
Regions: Global
|
Antiviral Therapeutics: Pipelines and Competitive Dynamics
Topics: AIDS, HIV & STDs
|
Latin American Rapid Test Markets for Infectious Diseases
Topics: AIDS, HIV & STDs, Immunoassays, Diagnostics
Regions: South America
|
HIV: A Strategic Analysis of Therapeutic and Testing Markets
Topics: In Vitro Diagnostics, AIDS, HIV & STDs
|
Executive Summary: HIV: A Strategic Analysis of Therapeutic and Testing Markets
Topics: AIDS, HIV & STDs
|
Securing a Competitive Advantage in the Reverse Transcriptase Market
Topics: Molecular Biology, AIDS, HIV & STDs
|
Pharmaceuticals and Politics: Will Political Opinion Affect the Future of HPV Vaccines?
Topics: AIDS, HIV & STDs, General Pharmaceuticals, Regulation & Policy, Women's Health
|
Stakeholder Opinions: Sexually Transmitted Infections - The Silent Menace
Topics: AIDS, HIV & STDs
|
Commercial Insight: Herpes and Respiratory Antivirals - Leaders Rise and Fall
Topics: AIDS, HIV & STDs, Vaccines
|
Stakeholder Insight: HIV - A way of life
Topics: AIDS, HIV & STDs
|
HIV Diagnostics: Key Disease Management Role Spells Opportunity
Topics: AIDS, HIV & STDs, Disease Management
|
Commercial Insight: HIV - Simplicity and Survival
Topics: AIDS, HIV & STDs
|
Biomedical Smart Report: HIV
Topics: AIDS, HIV & STDs
|
Pipeline Insight: HIV - Hold Your Horses
Topics: AIDS, HIV & STDs
|
Rapid Viral Testing
Topics: AIDS, HIV & STDs, Research & Development
|
Strategic Analysis of Global HIV Diagnostics and Monitoring Markets
Topics: AIDS, HIV & STDs
|
Stakeholder Opinions: HIV Vaccines - The Emperor Has No Clothes
Topics: AIDS, HIV & STDs, Vaccines
|
Commercial Insight: HIV - From the Naïve to the Complex
Topics: AIDS, HIV & STDs
|
Stakeholder Insight: HIV Related Neuropathic Pain - Useful Niche for Peripheral Companies
Topics: Pain, AIDS, HIV & STDs
|
Pipeline Insight: HIV - Enter the New Generation Inhibitors
Topics: AIDS, HIV & STDs
|
Stakeholder Opinions: HIV/ HBV Co-infection - More Potency, More Policy
Topics: AIDS, HIV & STDs
|
HIV Resistance: Impact and Evolution
Topics: AIDS, HIV & STDs
|
Stakeholder Opinions: HIV - Reaching the 'Untapped' Patient Population
Topics: AIDS, HIV & STDs
|
Stakeholder Opinions: HIV/HCV Co-infection - Whose Niche?
Topics: AIDS, HIV & STDs
|
Commercial Insight: HIV in the USA - Increasing Choice, Flexibility and Competition
Topics: AIDS, HIV & STDs
Regions: United States
|
U.S. Infectious Diseases: Sexually Transmitted Disease Diagnostics Markets
Topics: AIDS, HIV & STDs, Diseases & Conditions
Regions: United States
|
HIV Update 2002 (11) - November
Topics: AIDS, HIV & STDs
|
HIV Update 2002 (12) - December
Topics: AIDS, HIV & STDs
|
HIV Update 2003 (1) - January
Topics: AIDS, HIV & STDs
|
HIV Update 2003 (2) - February
Topics: AIDS, HIV & STDs
|
HIV Update 2003 (3) - March
Topics: AIDS, HIV & STDs
|
HIV Pricing Strategies in the US and UK
Topics: AIDS, HIV & STDs
Regions: United Kingdom, United States
|
